Psychiatry and Neurology, Neurology · West Reading, PA
NPI
1649281833
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
301 S 7th Ave
West Reading, PA, 19611
Phone (610) 372-0183
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
285 services
Medicare patients, 2024
174
Average age 70
Drug cost, 2024
$5.3M
3,203 prescriptions
Company payments, 2025
$2,142
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Clifford A Reed was code 99214 (office e&m - established), 260 times for 169 patients. In total Clifford A Reed billed 285 services in 5 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 260 | 169 | $62.49 | $16K |
By year: 2022 $37K for 452 services; 2023 $27K for 372 services; 2024 $18K for 285 services.
Medicare prescription drug claims, 2024
In 2024, the drug Clifford A Reed prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 203 prescriptions and refills. In total Clifford A Reed wrote 3,203 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 203 | 397 | 42 | $9,139 |
| Baclofen Generic | 178 | 325 | 38 | $4,454 |
| Levetiracetam Generic | 171 | 333 | 33 | $5,153 |
| Topiramate Generic | 155 | 326 | 36 | $1,990 |
| Carbamazepine Generic | 148 | 286 | 30 | $10K |
| Rizatriptan Rizatriptan Benzoate | 141 | 149 | 28 | $2,182 |
| Aimovig Autoinjector Erenumab-Aooe | 140 | 147 | 20 | $108K |
| Donepezil Hcl Generic | 128 | 290 | 41 | $1,635 |
| Gabapentin Generic | 113 | 148 | 22 | $2,719 |
| Memantine Hcl Generic | 108 | 224 | 27 | $3,027 |
| Sumatriptan Succinate Generic | 103 | 122 | 14 | $1,194 |
| Emgality Pen Galcanezumab-Gnlm | 96 | 112 | 12 | $76K |
| Teriflunomide Generic | 92 | 96 | 17 | $222K |
| Aubagio Teriflunomide | 78 | 86 | 11 | $776K |
| Dalfampridine Er Dalfampridine | 67 | 88 | 13 | $31K |
Brand drugs: 563 claims; generic drugs: 2,604 claims; opioid claims: 85.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Clifford A Reed $2,142 ($2,142 in general payments such as food, travel and fees) from 8 companies. The largest payer was EMD Serono, Inc. with $904.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.